Ju Won Kim

Phase III, Randomized Study of Atezolizumab Plus Bevacizumab and Chemotherapy in Patients With <i>EGFR</i>- or <i>ALK</i>-Rearranged or Translocated Non–Small-Cell Lung Cancer (ATTLAS, KCSG-LU19-04)

Sehhoon Park, Tae Min Kim, Ji‐Youn Han et al. · Journal of Clinical Oncology · 2023 · 141 citations · Full text

Brassinazole resistant 1 (BZR1)-dependent brassinosteroid signalling pathway leads to ectopic activation of quiescent cell division and suppresses columella stem cell differentiation

Hak-Soo Lee, Yoon Kim, Giang Pham et al. · Journal of Experimental Botany · 2015 · 61 citations · Full text

A prospective randomized study of gemcitabine with doxifluridine versus paclitaxel with doxifluridine in concurrent chemoradiotherapy for locally advanced pancreatic cancer

Hye Won Chung, Seungmin Bang, Seung Woo Park et al. · International Journal of Radiation Oncology*Biology*Physics · 2004 · 47 citations · Full text

Concurrent Chemoradiotherapy, Oncology, Pancreatic Cancer +9

Identification of Arabidopsis BAK1-Associating Receptor-Like Kinase 1 (BARK1) and Characterization of its Gene Expression and Brassinosteroid-Regulated Root Phenotypes

Min Hee Kim, Yoon Kim, Ju Won Kim et al. · Plant and Cell Physiology · 2013 · 34 citations

Plant Molecular Biology, Developmental Biology, Signal Transduction +14

Comparison of the Validity of Three Biomarkers for Gastric Cancer Screening

Hye Won Chung, Ju Won Kim, Jong-han Lee et al. · Journal of Clinical Gastroenterology · 2008 · 29 citations · Full text